Growth Hormone ELISA - Cosmo Bio Co.,Ltd.

Antibodies

>  

Growth Hormone ELISA

Catalog No.: ENC-ERKR7008
Size: 1KIT
Price: ¥125000
$1667
antigen/source: GH
Description: standard: native
catalog info: Catalog 2012-p111
Storage: 4C & -20C
@
Immunogen: Rodent
Reacts with: Mouse
Rat
Sensitive: 0.2 ng / mL
Purpose: Rodent GH ELISA is intended to quantitative determination of Growth Hormone (rGH) concentration in serum/plasma of rat and related species. The test is designed as research tool in evaluation of preclinical samples in rat and related species and should be employed by a trained/skilled professional.
component: Antibody: X
Plate: X
Coating: X
Control: -
Standard: X
Labeling: X
Substrate: X
Others: X
1. Antibody-coated microtiter wells, 96-well plate
2. Enzyme -Conjugate Diluent 12 mL
3. Enzyme conjugate (Orange cap tube Lyophilized)
4. Reference Standards (0, 1.0, 2.5, 10, 25, 50 ng/mL) + 10ml Standard diluent
5. TMB Color Reagent, 12 mL
6. Stop solution (2N HCl), 6 mL
7. 20x Washing Buffer, 25 mL.
8. Instructions

Other:

 Supplementary 
Sandwich
 Applicable sample 
Serum, Plasma
[Other]
Growth Hormone (is also called somatotropin) is secreted by the anterior pituitary gland and is under the influence of hypothalamic Growth Hormone Releasing Factor (GHRF).It has191 amino acids in length and has a molecular mass of approximately 22,000 daltons. There are a few structural similarities of growth hormone between species. Its metabolic effects are primarily anabolic. For example, human GH promotes proteinconservation and is engaged in a wide range of mechanisms for protein synthesis. It also enhances glucose transport and facilitates glycogen storage. Another family of peptide hormones, the somatomedins, mediates its cascade of growth-promoting action. Manyfactors are known to influence the rate of growth hormone secretion, including periods of sleep and wakefulness, exercise, stress, hypoglycemia, estrogens, corticosteroids and L-dopa.
The rat Growth Hormone Enzyme Immunoassay provides rapid,sensitiveand reliable results.


Reference:

•  Van Wyk JJ and Underwood LE 1978 Hospital Practice 13, p57
•  Fisher DA 1977 Nicholas AL and Nelson JCP 3498 Nichols Institute.
•  Goldfine ID 1978 Medical treatment of acromegaly Ann Rev of Med. 29, p407
•  Reichlin S et al., 1976 Hypothalamic hormones Ann Rev Med 27 p359
5. Rimoin DL and Horton WA. 1978 Short Stature J Pediatrics 92 p523
 
>